Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4

Laboratory Investigation

Volumn 89, Issue 11, 2009, Pages 1221-1228

  Byon, Chang Hyun ^a   Hardy, Robert W ^b   Ren, Changchun ^b   Ponnazhagan, Selvarangan ^b   Welch, Danny R ^a,b   McDonald, Jay M ^b,c   Chen, Yabing ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Breast cancer cell; Free fatty acids; Migration; PAI 1; SMAD4

Indexed keywords

COMPLEMENTARY RNA; FATTY ACID; PLASMINOGEN ACTIVATOR INHIBITOR 1; SMAD4 PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; OLIGORIBONUCLEOTIDES, ANTISENSE; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA, MESSENGER; RNA, NEOPLASM; SMAD4 PROTEIN;

EID: 70350681047     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.97     Document Type: Article

References (39)

1. Pi-Sunyer FX, Becker DM, Bouchard C, et al. Executive summary of the Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Arch Intern Med 1998;158:1855-1867.
2. Abu-Abid S, Szold A, Klausner J. Obesity and cancer. J Med 2002;33: 73-86.
3. Bergstrom A, Pisani P, Tenet V, et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-430.
4. Simopoulos AP. Energy imbalance and cancer of the breast, colon and prostate. Med Oncol Tumor Pharmacother 1990;7:109-120.
5. Loskutoff DJ, Samad F. The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol 1998;18:1-6.
6. Bani IA, Williams CM, Boulter PS, et al. Plasma lipids and prolactin in patients with breast cancer. Br J Cancer 1986;54:439-446.
7. Senzaki H, Iwamoto S, Ogura E, et al. Dietary effects of fatty acids on growth and metastasis of KPL-1 human breast cancer cells in vivo and in vitro. Anticancer Res 1998;18:1621-1627.
8. Hardy S, Langelier Y, Prentki M. Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. Cancer Res 2000;60:6353-6358.
9. Hardy S, El-Assaad W, Przybytkowski E, et al. Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. A role for cardiolipin. J Biol Chem 2003;278:31861-31870.
10. Alessi MC, Bastelica D, Morange P, et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 2000;49:1374-1380.
11. Bastard JP, Bruckert E, Robert JJ, et al. Are free fatty acids related to plasma plasminogen activator inhibitor 1 in android obesity? Int J Obes Relat Metab Disord 1995;19:836-838.
12. Binder BR, Christ G, Gruber F, et al. Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci 2002;17:56-61.
13. Foekens JA, Peters HA, Look MP, et al. The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. Cancer Res 2000;60:636-643.
14. Harbeck N, Thomssen C, Berger U, et al. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse. Breast Cancer Res Treat 1999;54:147-157.
15. Hamer PJ, Morris LD, Jarosz DE, et al. PAI-1 and uPA:PAI-1 complex levels in normal plasma and elevations in cancer plasma [abstract]. In: Kolodner RD (ed.), Proceedings of the 93rd Annual Meeting of the American Association for Cancer Research, 2002, Abstract no. 4496.
16. Hamer PJ, Goshgarian N, Smith J. Plasma PAI-1 and uPA:PAI-1 complex levels a predictive and prognostic factors in patients with metastatic breast cancer [abstract]. In: Courtneidge SA (ed.), Proceedings of the 94th Annual Meeting of the American Association for Cancer Research, 2003, Abstract no. 6356.
17. Zhang X, Shu XO, Cai Q, et al. Functional plasminogen activator inhibitor-1 gene variants and breast cancer survival. Clin Cancer Res 2006;12:6037-6042.
18. Chen Y, Sobel BE, Schneider DJ. Effect of fatty acid chain length and thioesterification on the augmentation of expression of plasminogen activator inhibitor-1. Nutr Metab Cardiovasc Dis 2002;12:325-330.
19. Chen Y, Schneider DJ. The independence of signaling pathways mediating increased expression of plasminogen activator inhibitor type 1 in HepG2 cells exposed to free fatty acids or triglycerides. Int J Exp Diabetes Res 2002;3:109-118.
20. Chen Y, Billadello JJ, Schneider DJ. Identification and localization of a fatty acid response region in the human plasminogen activator inhibitor-1 gene. Arterioscler Thromb Vasc Biol 2000;20: 2696-2701.
21. Castello R, Estelles A, Vazquez C, et al. Quantitative real-time reverse transcription-PCR assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1, and tissue metalloproteinase inhibitor type 1 gene expressions in primary breast cancer. Clin Chem 2002;48:1288-1295.
22. Ponnazhagan S, Mahendra G, Kumar S, et al. Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor. Cancer Res 2004;64:1781-1787.
23. Liu L, Santora R, Rao JN, et al. Activation of TGF-beta-Smad signaling pathway following polyamine depletion in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2003;285:G1056-G1067.
24. Hilakivi-Clarke L, Onojafe I, Raygada M, et al. Breast cancer risk in rats fed a diet high in n-6 polyunsaturated fatty acids during pregnancy. J Natl Cancer Inst 1996;88:1821-1827.
25. Chajès V, Sattler W, Stranzl A, et al. Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E. Breast Cancer Res Treat 1995;34:199-212.
26. Ramachandra M, Atencio I, Rahman A, et al. Restoration of transforming growth factor beta signaling by functional expression of smad4 induces anoikis. Cancer Res 2002;62:6045-6051.
27. Stoll BA. Breast cancer and the western diet: role of fatty acids and antioxidant vitamins. Eur J Cancer 1998;34:1852-1856.
28. Byon CH, Hardy RW, Welch DR, et al. Augmentation of plasminogen activator inhibitor-1 by free fatty acids in breast cancer cells [abstract]. In: Haber DA (ed.), Proceedings of the 97th Annual Meeting of the American Association for Cancer Research, 2006, Abstract no. 4374.
29. Dong-Le Bourhis X, Lambrecht V, Boilly B. Transforming growth factor beta 1 and sodium butyrate differentially modulate urokinase plasminogen activator and plasminogen activator inhibitor-1 in human breast normal and cancer cells. Br J Cancer 1998;77:396-403.
30. Malchoff CD, Pohl SL, Kaiser DL, et al. Determinants of glucose and ketoacid concentrations in acutely hyperglycemic diabetic patients. Am J Med 1984;77:275-285.
31. Wirth A, Neermann G, Eckert W, et al. Metabolic response to heavy physical exercise before and after a 3-month training period. Eur J Appl Physiol Occup Physiol 1979;41:51-59.
32. Dellas C, Loskutoff DJ. Historical analysis of PAI-1 from its discovery to its potential role in cell motility and disease. Thromb Haemost 2005;93:631-640.
33. Bajou K, Lewalle JM, Martinez CR, et al. Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression. Int J Cancer 2002;100: 501-506.
34. Siri S, Chen MJ, Chen TT. Inhibition of human breast cancer cell (MBA-MD-231) invasion by the Ea4-peptide of rainbow trout pro-IGF-I. J Cell Biochem 2006;99:1363-1373.
35. Rose DP, Connolly JM, Liu XH. Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res 1994;54:6557-6562.
36. Earashi M, Noguchi M, Kinoshita K, et al. Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Oncology 1995;52: 150-155.
37. Liu XH, Connolly JM, Rose DP. Eicosanoids as mediators of linoleic acid-stimulated invasion and type IV collagenase production by a metastatic human breast cancer cell line. Clin Exp Metastasis 1996;14:145-152.
38. Minisini AM, Fabbro D, Di Loreto C, et al. Markers of the uPA system and common prognostic factors in breast cancer. Am J Clin Pathol 2007;128:112-117.
39. Gutierrez LS, Schulman A, Brito-Robinson T, et al. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res 2000;60:5839-5847.